Scleromyxedema, a Positive Effect with Thalidomide
- 1 August 2006
- journal article
- case report
- Published by S. Karger AG in Dermatology
- Vol. 213 (2) , 150-152
- https://doi.org/10.1159/000093856
Abstract
Scleromyxedema is a rare dermatological disorder marked by Wide spread symmetric 2-to 3-mm, firm, waxy, closely spaced papules involving the hands, forearms, face, neck, upper trunk and thighs. The most common extracutaneous manifestation of scleromyxedema is a benign plasma cell dyscrasia. Treatment of scleromyxedema is limited by the lack of long-term results, toxicity and significant adverse side effects. We report a severe case of scleromyxedema who had marked improvement when treated with thalidomide.Keywords
This publication has 32 references indexed in Scilit:
- A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedemaJournal of the American Academy of Dermatology, 2004
- Diffuse cutaneous mucinosesDermatologic Clinics, 2002
- Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedemaJournal of the American Academy of Dermatology, 2001
- Scleromyxedema: A Complete Response to PrednisoneMayo Clinic Proceedings, 1999
- ScleromyxedemaJournal of the American Academy of Dermatology, 1995
- Regression of scleromyxedema with topical betamethasone and dimethyl sulfoxide: a 30-month follow-upArchives of Dermatology, 1991
- Improvement of scleromyxedema associated with isotretinoin therapyJournal of the American Academy of Dermatology, 1991
- Scleromyxedema: Therapeutic response to isotretinoin in three patientsJournal of the American Academy of Dermatology, 1988
- PUVA treatment of scleromyxoedemaBritish Journal of Dermatology, 1984
- Lichen Myxedematosus Serum Stimulates Human Skin Fibroblast ProliferationScience, 1978